Morgan Stanley’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Sell |
154,928
-976,104
| -86% | -$9.36M | ﹤0.01% | 4891 |
|
|
2025
Q1 | $7.09M | Buy |
1,131,032
+164,632
| +17% | +$1.03M | ﹤0.01% | 3622 |
|
|
2024
Q4 | $7.85M | Buy |
966,400
+526,910
| +120% | +$4.28M | ﹤0.01% | 3606 |
|
|
2024
Q3 | $7.95M | Sell |
439,490
-323,107
| -42% | -$5.84M | ﹤0.01% | 3609 |
|
|
2024
Q2 | $7.85M | Buy |
762,597
+525,437
| +222% | +$5.41M | ﹤0.01% | 3506 |
|
|
2024
Q1 | $2.52M | Sell |
237,160
-11,942
| -5% | -$127K | ﹤0.01% | 4430 |
|
|
2023
Q4 | $2.27M | Buy |
249,102
+170,858
| +218% | +$1.56M | ﹤0.01% | 4856 |
|
|
2023
Q3 | $811K | Buy |
78,244
+5,862
| +8% | +$60.8K | ﹤0.01% | 4917 |
|
|
2023
Q2 | $1.04M | Sell |
72,382
-21,316
| -23% | -$305K | ﹤0.01% | 4804 |
|
|
2023
Q1 | $669K | Buy |
93,698
+24,510
| +35% | +$175K | ﹤0.01% | 5087 |
|
|
2022
Q4 | $776K | Sell |
69,188
-23,242
| -25% | -$261K | ﹤0.01% | 5007 |
|
|
2022
Q3 | $1.03M | Sell |
92,430
-16,432
| -15% | -$182K | ﹤0.01% | 4860 |
|
|
2022
Q2 | $919K | Buy |
108,862
+24,262
| +29% | +$205K | ﹤0.01% | 5066 |
|
|
2022
Q1 | $1.15M | Sell |
84,600
-54,568
| -39% | -$742K | ﹤0.01% | 4892 |
|
|
2021
Q4 | $2.74M | Buy |
139,168
+112,435
| +421% | +$2.21M | ﹤0.01% | 4320 |
|
|
2021
Q3 | $857K | Buy |
26,733
+241
| +0.9% | +$7.73K | ﹤0.01% | 5148 |
|
|
2021
Q2 | $896K | Buy |
26,492
+26,433
| +44,802% | +$894K | ﹤0.01% | 5142 |
|
|
2021
Q1 | $2K | Sell |
59
-7,874
| -99% | -$267K | ﹤0.01% | 7278 |
|
|
2020
Q4 | $264K | Buy |
7,933
+6,838
| +624% | +$228K | ﹤0.01% | 5444 |
|
|
2020
Q3 | $40K | Sell |
1,095
-2,237
| -67% | -$81.7K | ﹤0.01% | 5803 |
|
|
2020
Q2 | $110K | Buy |
3,332
+2,500
| +300% | +$82.5K | ﹤0.01% | 5359 |
|
|
2020
Q1 | $21K | Sell |
832
-13,609
| -94% | -$343K | ﹤0.01% | 5795 |
|
|
2019
Q4 | $450K | Buy |
+14,441
| New | +$450K | ﹤0.01% | 4984 |
|